Back
AN2 Therapeutics Stock Price Chart
Sponsored
ANTX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
ANTX
AN2 Therapeutics
Last Price:
1.35
Seasonality Move:
-36.32%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANTX is experiencing slight buying pressure.
AN2 Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.12 | Buy |
20-day SMA: | 1.1 | Buy |
50-day SMA: | 1.07 | Buy |
200-day SMA: | 2.15 | Sell |
8-day EMA: | 1.17 | Buy |
20-day EMA: | 1.12 | Buy |
50-day EMA: | 1.16 | Buy |
200-day EMA: | 3.51 | Sell |
AN2 Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 72.02 | Buy |
Chaikin Money Flow: | 4705 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.02 - 1.18) | Buy |
Bollinger Bands (100): | (0.78 - 2.14) | Sell |
AN2 Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for AN2 Therapeutics Stock
Is AN2 Therapeutics Stock a Buy?
- AN2 Therapeutics share price is 1.34 while ANTX 8-day simple moving average is 1.12, which is a Buy signal.
- The stock price of ANTX is 1.34 while AN2 Therapeutics 20-day SMA is 1.10, which makes it a Buy.
- AN2 Therapeutics 50-day simple moving average is 1.07 while ANTX share price is 1.34, making it a Buy technically.
- ANTX stock price is 1.34 and AN2 Therapeutics 200-day simple moving average is 2.15, creating a Sell signal.
ANTX Technical Analysis vs Fundamental Analysis
Sell
48
AN2 Therapeutics (ANTX)
is a Sell
Is AN2 Therapeutics a Buy or a Sell?
-
AN2 Therapeutics stock is rated a Sell
The current AN2 Therapeutics [ANTX] share price is $1.34. The Score for ANTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
AN2 Therapeutics Stock Info
Market Cap:
40.04M
Price in USD:
1.34
Share Volume:
1.25M
AN2 Therapeutics 52-Week Range
52-Week High:
22.22
52-Week Low:
0.87
Sell
48
AN2 Therapeutics (ANTX)
is a Sell
AN2 Therapeutics Share Price Forecast
-
What is the AN2 Therapeutics stock price today?
The AN2 Therapeutics stock price is 1.34 USD today. -
Will ANTX stock go up or go down?
AN2 Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is AN2 Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, AN2 Therapeutics is overvalued.
Is AN2 Therapeutics Stock a Buy?
- AN2 Therapeutics share price is 1.34 while ANTX 8-day exponential moving average is 1.17, which is a Buy signal.
- The stock price of ANTX is 1.34 while AN2 Therapeutics 20-day EMA is 1.12, which makes it a Buy.
- AN2 Therapeutics 50-day exponential moving average is 1.16 while ANTX share price is 1.34, making it a Buy technically.
- ANTX stock price is 1.34 and AN2 Therapeutics 200-day simple moving average is 3.51, creating a Sell signal.
Fundamental Analysis of AN2 Therapeutics
Is AN2 Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.49 per share, and an increase next year of $0.29 per share.
Technical Analysis of AN2 Therapeutics
Should I short AN2 Therapeutics stock?
- ANTX Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting AN2 Therapeutics is a Buy
- AN2 Therapeutics Relative Strength Index (RSI) is 72.02, which suggest AN2 Therapeutics is overbought
- The Bollinger Bands (25) for AN2 Therapeutics is (1.02 - 1.18), which suggest AN2 Therapeutics is a Sell
- The Bollinger Bands (100) for AN2 Therapeutics is (0.78 - 2.14), which suggest AN2 Therapeutics is a Sell
* AN2 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.